You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API gilteritinib

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing gilteritinib

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Astellas Pharma US Inc	XOSPATA	gilteritinib	0469-1425	FERRIC OXIDE RED	2036-07-01
Astellas Pharma US Inc	XOSPATA	gilteritinib	0469-1425	HYDROXYPROPYL CELLULOSE	2036-07-01
Astellas Pharma US Inc	XOSPATA	gilteritinib	0469-1425	HYPROMELLOSE	2036-07-01
Astellas Pharma US Inc	XOSPATA	gilteritinib	0469-1425	LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE	2036-07-01
Astellas Pharma US Inc	XOSPATA	gilteritinib	0469-1425	MAGNESIUM STEARATE	2036-07-01
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for gilteritinib

Excipient focus: FERRIC OXIDE RED

gilteritinib drug variants containing FERRIC OXIDE RED

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Astellas Pharma US Inc	gilteritinib	0469-1425
>Company	>Ingredient	>NDC

gilteritinib drug variants not containing FERRIC OXIDE RED

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYPROPYL CELLULOSE

gilteritinib drug variants containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Astellas Pharma US Inc	gilteritinib	0469-1425
>Company	>Ingredient	>NDC

gilteritinib drug variants not containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE

gilteritinib drug variants containing HYPROMELLOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Astellas Pharma US Inc	gilteritinib	0469-1425
>Company	>Ingredient	>NDC

gilteritinib drug variants not containing HYPROMELLOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

gilteritinib drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Astellas Pharma US Inc	gilteritinib	0469-1425
>Company	>Ingredient	>NDC

gilteritinib drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

gilteritinib drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Astellas Pharma US Inc	gilteritinib	0469-1425
>Company	>Ingredient	>NDC

gilteritinib drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

gilteritinib drug variants containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Astellas Pharma US Inc	gilteritinib	0469-1425
>Company	>Ingredient	>NDC

gilteritinib drug variants not containing MANNITOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL

gilteritinib drug variants containing POLYETHYLENE GLYCOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Astellas Pharma US Inc	gilteritinib	0469-1425
>Company	>Ingredient	>NDC

gilteritinib drug variants not containing POLYETHYLENE GLYCOL

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TALC

gilteritinib drug variants containing TALC

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Astellas Pharma US Inc	gilteritinib	0469-1425
>Company	>Ingredient	>NDC

gilteritinib drug variants not containing TALC

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

gilteritinib drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
Astellas Pharma US Inc	gilteritinib	0469-1425
>Company	>Ingredient	>NDC

gilteritinib drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.